NCPA submits comments on “off-label prescribing” bill in Ohio

NCPA June 25, 2024

Earlier this month, NCPA submitted comments on Ohio’s House Bill 73, which would require pharmacists to dispense all “off-label” prescriptions for any use unless the pharmacist has a religious objection or is aware of a life-threatening contraindication. Off-label prescribing is common and can be safe, however, this legislation removes pharmacists from the process, undercutting a serious check in patient care. The bill has advanced from its original chamber and has had its second hearing in the Senate.

NCPA